Humana Inc. (HUM)
- Previous Close
364.20 - Open
362.73 - Bid --
- Ask 377.22 x 800
- Day's Range
358.04 - 363.40 - 52 Week Range
298.61 - 530.54 - Volume
1,349,641 - Avg. Volume
1,667,395 - Market Cap (intraday)
43.485B - Beta (5Y Monthly) 0.50
- PE Ratio (TTM)
22.22 - EPS (TTM)
16.24 - Earnings Date Aug 1, 2024
- Forward Dividend & Yield 3.54 (0.98%)
- Ex-Dividend Date Jun 28, 2024
- 1y Target Est
368.76
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
www.humana.comRecent News: HUM
Performance Overview: HUM
Trailing total returns as of 6/4/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HUM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HUM
Valuation Measures
Market Cap
43.49B
Enterprise Value
50.79B
Trailing P/E
22.22
Forward P/E
22.37
PEG Ratio (5yr expected)
1.64
Price/Sales (ttm)
0.41
Price/Book (mrq)
2.70
Enterprise Value/Revenue
0.46
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.82%
Return on Assets (ttm)
4.91%
Return on Equity (ttm)
12.10%
Revenue (ttm)
109.24B
Net Income Avi to Common (ttm)
1.99B
Diluted EPS (ttm)
16.24
Balance Sheet and Cash Flow
Total Cash (mrq)
22.61B
Total Debt/Equity (mrq)
83.68%
Levered Free Cash Flow (ttm)
-6.82B